Literature DB >> 17406834

Serum total sialic acid in differential diagnostics of jaundice caused by malignant and nonmalignant diseases: a ROC curve analysis.

Bogdan Cylwik1, Lech Chrostek, Bogdan Zalewski, Andrzej Dabrowski, Maciej Szmitkowski.   

Abstract

The purpose of this study was to evaluate the usefulness of serum total sialic acid (SA) for discrimination of malignant and nonmalignant jaundice. Serum SA concentration and its ratio with total protein (SA/TP) were determined in 55 patients with jaundice: 25 malignant and 30 nonmalignant. SA was estimated by enzymatic method. Serum total SA and the ratio SA/TP were significantly higher in malignant than in nonmalignant jaundice. Diagnostic sensitivity of SA and the ratio of SA/TP in both types of jaundice reached the value of 95.8%. The specificity, positive and negative predictive values, and efficiency of SA and SA/TP were higher in malignant than in nonmalignant jaundice. Areas under ROC curves for SA and the ratio of SA/TP in malignant jaundice were higher than in nonmalignant, but there were not statistically significant differences. SA levels and the ratio of SA/TP do not have the ability to discriminate between these types of jaundice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406834     DOI: 10.1007/s10620-006-9640-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Total and lipid-bound serum sialic acid in benign and malignant breast disease.

Authors:  J Romppanen; M Eskelinen; S Tikanoja; I Mononen
Journal:  Anticancer Res       Date:  1997 Mar-Apr       Impact factor: 2.480

2.  Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis.

Authors:  S Wongkham; C Boonla; S Kongkham; C Wongkham; V Bhudhisawasdi; B Sripa
Journal:  Clin Biochem       Date:  2001-10       Impact factor: 3.281

Review 3.  Molecular changes in carbohydrate antigens associated with cancer.

Authors:  A Singhal; S Hakomori
Journal:  Bioessays       Date:  1990-05       Impact factor: 4.345

4.  [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].

Authors:  X Shi; Y Zhou; L Xia
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1998-11

Review 5.  The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.

Authors:  E M Schutter; J J Visser; G J van Kamp; S Mensdorff-Pouilly; W van Dijk; J Hilgers; P Kenemans
Journal:  Tumour Biol       Date:  1992

6.  Serum sialic acid--an important cancer marker.

Authors:  S L Tewarson; V P Mittal; M Singh; G P Gupta
Journal:  Indian J Cancer       Date:  1993-09       Impact factor: 1.224

7.  Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.

Authors:  G Verazin; W M Riley; J Gregory; C Tautu; J J Prorok; J A Alhadeff
Journal:  Dis Colon Rectum       Date:  1990-02       Impact factor: 4.585

8.  Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features.

Authors:  M J Vierbuchen; W Fruechtnicht; S Brackrock; K T Krause; T J Zienkiewicz
Journal:  Cancer       Date:  1995-09-01       Impact factor: 6.860

9.  Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells.

Authors:  E H Holmes; G K Ostrander; S Hakomori
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

10.  Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.

Authors:  G N Raval; D D Patel; L J Parekh; J B Patel; M H Shah; P S Patel
Journal:  Oral Dis       Date:  2003-05       Impact factor: 3.511

View more
  1 in total

1.  The relationship between serum sialic acid and high-sensitivity C-reactive protein with prehypertension.

Authors:  Li Jinghua; Zhang Tie; Wang Ping; Cao Yongtong
Journal:  Med Sci Monit       Date:  2014-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.